Aptuit, Inc. Develops Advanced Solid-State Chemistry Production Screen to Address Challenges in the Drug Development Process

GREENWICH, Conn.--(BUSINESS WIRE)--Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process. Using this screen to provide an increased understanding of the characteristics of a drug compound, Aptuit is better able to offer data and insights that inform critical decisions, particularly around potential scale-up challenges, at both the development and production stages of drug development programs.

Back to news